 stroke prevent atrial fibril studi final result background atrial fibril absenc rheumat valvular diseas fivefold risk ischem stroke method main result stroke prevent atrial fibril studi multicent trial mg/day aspirin double-blind placebo prevent ischem stroke system embol primari event inpati outpati constant intermitt atrial fibril mean follow-up year rate primari event patient year year confid interv subgroup warfarin-elig patient year old warfarin dose-adjust prothrombin time control risk primari event warfarin versu placebo year confid interv primari event death warfarin aspirin risk signific bleed year patient aspirin placebo conclus aspirin warfarin effect ischem stroke system embol patient atrial fibril warfarin-elig patient subset aspirin-elig patient magnitud reduct event warfarin versu aspirin too event warfarin-elig patient rel benefit aspirin warfarin trial issu patient nonrheumat atrial fibril prophylact antithrombot therapi risk stroke